Bayer Consumer Care praises USPSTF’s recommendation of broader use of aspirin
MORRISTOWN, N.J. Bayer Consumer Care on Tuesday commended the U.S. Preventive Services Task Force’s recent support of broader use of aspirin in the prevention of heart attack and stroke.
“[Tuesday’s] recommendations add support for broader appropriate uses of aspirin and do not affect the already [Food and Drug Administration]-approved indications for prevention of recurrent heart attack and stroke, as well as reduction of the risk of death when taken during a suspected heart attack,” Bayer stated. “Further, it’s important that those on doctor-recommended aspirin treatment regimens do not stop taking aspirin without consulting with their doctor as research shows that aspirin withdrawal actually puts patients at higher risk for a cardiovascular event.”
The new recommendations provide more specific guidance on aspirin use, providing clarity on maximizing benefits and minimizing risk, Bayer suggested. To help increase awareness around appropriate use of aspirin as a prophylactic to heart disease, Bayer is introducing “Is Aspirin Right For Me?” — a downloadable discussion guide available at http://www.wonderdrug.com/ to help consumers have meaningful conversations with their healthcare providers to together determine if aspirin is right for them.
“Bayer applauds the USPSTF for today’s important announcement,” stated Wes Cetnarowski, SVP global research and development at Bayer Healthcare. “These recommendations are consistent with our ongoing commitment to advancing appropriate aspirin use to reduce the personal and public health impact of cardiovascular disease.”
The USPSTF granted its highest level of evidence rating encouraging the use of low-dose aspirin in men over 45 and women over 55 to prevent first heart attack and ischemic stroke respectively, when the benefits outweigh the risks. The guidance specific to women is based on results from the Women’s Health Study.
As stated in the Annals of Internal Medicine accompanying editorial, Aspirin for Prevention and Treatment of Cardiovascular Disease, “in women older than 65 years, the WHS did demonstrate a clear 26% reduction in [myocardial infarction]: the same risk reduction as occurred in primary prevention trials of aspirin in men.”
In addition, the new recommendations advise caution with respect to aspirin use in men and women 80 and above.
Hyland’s Borneman receives honorary degree from University of Sciences in Philadelphia
KING OF PRUSSIA, Pa. The University of Sciences in Philadelphia recently awarded an honorary doctorate of science degree to Hyland’s Jack Borneman, III, Hyland’s announced Tuesday.
The honor was granted at the University’s 188th Founders’ Day celebration and is in recognition of Borneman’s lifetime commitment to the development and regulation of homeopathic medicine within the United States.
“We are very proud to have Jack Borneman as a member of our team,” stated Jack’s son J.P. Borneman, chairman and CEO, Hyland’s. “We are especially pleased to have University of the Sciences honor his lifetime of work with this honorary degree. His work in homeopathic medicine has been passionate and ceaseless. As this industry grows, we know we owe a tremendous sense of gratitude to [Jack] and his contemporaries for all they have done and continue to do.”
University president Philip Gerbino addressed Borneman’s leadership in the healthcare industry, stating that, “[He] has been at the forefront of standards and change for homeopathy, creating a foundation from which future generations of homeopaths can continue to build upon.”
In 1980, Jack Borneman was a founding director of the newly incorporated Homoeopathic Pharmacopoeia Convention of the United States, and in 1983, he was elected the second president of the organization.
In the course of his 25 years as president, his leadership evolved HPCUS into a respected international body of scientists and experts consulted by governments worldwide as the leader in homeopathic regulation. His work has led to the wide availability of standardized, high-quality medications to the general public. In August 2008, Borneman assumed the role of HPCUS chairman.
Naturally Vitamins launches dietary supplement for food intolerances
PHOENIX Naturally Vitamins last week launched Histame, a dietary supplement formula for consumers who suffer from food intolerance.
The active ingredient in Histame, enzyme diamine oxidase, has been acknowledged by the Food and Drug Administration as a new dietary ingredient, the company noted.
It is estimated that up to 25% of the population suffers from food intolerance, an adverse reaction to foods rich in histamine due to a deficiency of the body’s digestive enzyme. Effects can range from common digestive problems including abdominal pain and spasms, diarrhea, constipation and flatulence, to facial flushing, headaches, nasal congestion, skin rash and itching.
Histamine levels are naturally high in certain foods, including bananas, pizza, tomatoes, chocolate, select cheese, processed and smoked meats, sausages, coffee, wine and beer.
Many food intolerances are confused with food allergies, Naturally Vitamins noted, explaining that a food allergy is an abnormal response to food, triggered by the body’s immune system. In contrast, nonallergenic histamine food intolerance is mostly brought on by foods not processed properly in the intestinal tract.